Matches in Wikidata for { <http://www.wikidata.org/entity/Q99409031> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q99409031 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q99409031 description "scientific article published on 01 June 2020" @default.
- Q99409031 description "wetenschappelijk artikel" @default.
- Q99409031 description "наукова стаття, опублікована 1 червня 2020" @default.
- Q99409031 name "Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors" @default.
- Q99409031 name "Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors" @default.
- Q99409031 type Item @default.
- Q99409031 label "Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors" @default.
- Q99409031 label "Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors" @default.
- Q99409031 prefLabel "Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors" @default.
- Q99409031 prefLabel "Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors" @default.
- Q99409031 P1433 Q99409031-FF444A11-C561-421A-95ED-B03F29B4ED5A @default.
- Q99409031 P1476 Q99409031-EB6268E5-79AD-4CDA-93DD-40F79799B6C6 @default.
- Q99409031 P304 Q99409031-791BECEF-BF48-46BD-B0FE-921FE7A6522E @default.
- Q99409031 P31 Q99409031-1898EDF0-D795-492F-9AC6-40652DC86525 @default.
- Q99409031 P356 Q99409031-28046FCC-8DB0-4705-85BD-A78FE214D730 @default.
- Q99409031 P478 Q99409031-543F4FAA-469A-4DA9-BBC4-15A84B54C018 @default.
- Q99409031 P50 Q99409031-068F6B4D-ADBD-4538-BB7A-04F6FC1BA788 @default.
- Q99409031 P50 Q99409031-77EF8688-9DBB-48BA-B09C-74FFCD55C8F2 @default.
- Q99409031 P50 Q99409031-78A86452-B61B-4DB3-BD58-E75A8984DAE8 @default.
- Q99409031 P50 Q99409031-88E108AD-2468-449E-901F-8499F2C9C7C2 @default.
- Q99409031 P577 Q99409031-F5392DB7-DD48-4B13-A43F-9F236234AC5B @default.
- Q99409031 P698 Q99409031-2AB17041-8510-45A7-AAC4-2147D3AA9A86 @default.
- Q99409031 P932 Q99409031-295D8721-0E64-4F64-AEFA-E6C48F58BACE @default.
- Q99409031 P356 ETAT.2020.00009 @default.
- Q99409031 P698 32924028 @default.
- Q99409031 P1433 Q96700988 @default.
- Q99409031 P1476 "Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors" @default.
- Q99409031 P304 "131-152" @default.
- Q99409031 P31 Q13442814 @default.
- Q99409031 P356 "10.37349/ETAT.2020.00009" @default.
- Q99409031 P478 "1" @default.
- Q99409031 P50 Q61314663 @default.
- Q99409031 P50 Q89035894 @default.
- Q99409031 P50 Q99409028 @default.
- Q99409031 P50 Q99409029 @default.
- Q99409031 P577 "2020-06-01T00:00:00Z" @default.
- Q99409031 P698 "32924028" @default.
- Q99409031 P932 "7116064" @default.